Gainers
- Ocera Therapeutics Inc OCRX shares jumped 68.5 percent to $1.68 after the company agreed to be acquired by Mallinckrodt PLC MNK for $1.52 per share.
- Payment Data Systems, Inc. PYDS shares gained 42.3 percent to $3.43 after falling 6.95 percent on Wednesday.
- AAC Holdings Inc AAC climbed 41.9 percent to $10.71 after the company posted better-than-expected Q3 earnings.
- Xenetic Biosciences Inc XBIO shares surged 40.7 percent to $3.11 as the company reported a Sublicense deal with Shire's Baxalta for PolyXen technology.
- Diana Containerships Inc DCIX shares rose 28.6 percent to $2.70.
- Electro Scientific Industries, Inc. ESIO gained 28.1 percent to $20.90 as the company reported upbeat Q2 results and issued a strong Q3 forecast.
- Almost Family Inc AFAM shares jumped 23.4 percent to $49.85.
- Ion Geophysical Corp IO shares rose 22.4 percent to $9.55 following Q3 results. Ion Geophysical reported Q3 profit of $4.9 million.
- DURECT Corporation DRRX surged 20.2 percent to $0.950 on upbeat Q3 earnings.
- Westell Technologies Inc. WSTL climbed 19.8 percent to $3.39. Westell Technologies reported Q2 adjusted earnings of $0.11 per share on revenue of $17.2 million.
- Attunity Ltd ATTU shares surged 19.2 percent to $7.83 after the company reported Q3 results and named Mark Logan as Chief Operating Officer.
- Neurocrine Biosciences, Inc. NBIX climbed 17.9 percent to $71.82 after the company reported strong results for its third quarter.
- Resolute Forest Products Inc RFP shares rose 16.2 percent to $6.80. Resolute reported preliminary Q3 earnings of $0.26 per share on sales of $885 million.
- SunPower Corporation SPWR gained 15.4 percent to $8.23 on strong Q3 results.
- Amedisys Inc AMED surged 15.4 percent to $53.59. Benchmark upgraded Amedisys from Hold to Buy, while Mizuho upgraded the stock from Neutral to Buy.
- TransAct Technologies Incorporated TACT shares jumped 15.2 percent to $11.29 on better-than-expected Q3 results.
- Alnylam Pharmaceuticals, Inc. ALNY gained 15 percent to $139.27 after the company disclosed ‘positive’ results from Phase 3 APOLLO study of patisiran.
- Titan International Inc TWI rose 14.7 percent to $11.19 as the company posted upbeat quarterly results.
- China Internet Nationwide Fncl Srvcs Inc CIFS shares gained 14.6 percent to $34.60 after dropping 27.05 percent on Wednesday.
- Energy Recovery, Inc. ERII shares rose 13.9 percent to $8.74.
- AxoGen, Inc. AXGN climbed 13.3 percent to $23.35 on narrower-than-expected Q3 loss.
- Endeavour Silver Corp EXK rose 12.1 percent to $2.22 following Q3 results.
- Tenaris SA (ADR) TS gained 8.3 percent to $29.63. Tenaris reported Q3 earnings of $0.09 per share on sales of $1.303 billion.
- Dicerna Pharmaceuticals Inc DRNA shares gained 7.8 percent to $6.08. Boehringer Ingelheim and Dicerna reported a research collaboration to develop novel treatments for chronic liver diseases including nonalcoholic steatohepatitis.
- L Brands Inc LB shares climbed 7.3 percent to $46.80 after reporting encouraging October sales data.
- Exelixis, Inc. EXEL gained 6.8 percent to $25.88. Exelixis reported Q3 adjusted earnings of $0.26 per share on revenue of $152.5 million.
Losers
- Cartesian Inc CRTN shares dipped 39.7 percent to $0.272 after the company reported the exploration of strategic alternatives. The company announced resignation of Peter Woodward as CEO and John Ferrara as CFO.
- IMPINJ Inc PI shares dropped 32.5 percent to $22.14 after Q3 earnings. The company's Q4 guidance fell way below estimates.
- KEMET Corporation KEM shares tumbled 29 percent to $17.62. Kemet reported preliminary Q2 adjusted earnings of $0.45 per share on sales of $301.5 million.
- Triangle Capital Corporation TCAP shares fell 26.5 percent to $9.00 after the company posted downbeat Q3 earnings and announced plans to explore strategic alternatives.
- Newell Brands Inc NWL dropped 26.1 percent to $30.29 as the company posted weaker-than-expected Q3 results and lowered its forecast.
- TreeHouse Foods Inc. THS fell 25.1 percent to $49.72 as the company posted downbeat quarterly earnings and announced a $400 million buyback. The company also announced the resignation of its President Robert B. Aiken.
- OraSure Technologies, Inc. OSUR declined 23.6 percent to $14.53. OraSure posted Q3 earnings of $0.09 per share on revenue of $42.3 million.
- Habit Restaurants Inc HABT dropped 22.7 percent to $9.55 on downbeat quarterly earnings. Baird downgraded Habit Restaurants from Outperform to Neutral.
- Microvision, Inc. MVIS fell 22.4 percent to $1.72 as the company announced Q3 results.
- ARC Document Solutions Inc ARC shares tumbled 22.1 percent to $ 3.46 as the company posted downbeat quarterly earnings and lowered its FY17 guidance.
- Cobalt International Energy, Inc. CIE dropped 21.5 percent to $ 0.785. Cobalt International Energy posted quarterly GAAP loss of $5.05 per share on revenue of $14.43 million.
- Oclaro Inc OCLR declined 20.6 percent to $6.36, despite a Q1 earnings beat.
- Wayfair Inc W shares dropped 19.7 percent to $59.77 after reporting downbeat Q3 results.
- Teva Pharmaceutical Industries Ltd (ADR) TEVA slipped 19.1 percent to $11.34 after the company reported downbeat results for its third quarter and lowered its 2017 guidance.
- AMAG Pharmaceuticals, Inc. AMAG dropped 17.2 percent to $ 13.20. AMAG Pharmaceuticals reported a Q3 loss of $152.1 million.
- Heska Corp HSKA slipped 17.1 percent to $80.45. Heska posted Q3 earnings of $0.40 per share on revenue of $31.4 million. The company also lowered its FY 2017 sales guidance.
- FreightCar America, Inc. RAIL fell 15.6 percent to $16.01 after the company posted a wider-than-expected Q3 loss.
- Tempur Sealy International Inc TPX declined 13.8 percent to $ 57.30. Tempur Sealy posted upbeat Q3 earnings, but sales missed estimates.
- GoPro Inc GPRO dropped 12.8 percent to $9.30. GoPro reported better-than-expected earnings for its third quarter. However, the company issued a weak Q4 guidance, with EPS in the range of 37 cents-47 cents, well short of Wall Street's 56-cent estimate.
- Intellia Therapeutics Inc NTLA declined 12.4 percent to $22.32. Intellia Therapeutics priced its 6.25 million share offering at $24.00 per share.
- Cellectis SA (ADR) CLLS shares declined 11.8 percent to $26.02 after dropping 16.65 percent on Wednesday.
- Epizyme Inc EPZM dropped 11.5 percent to $14.30. Epizyme posted a Q3 loss of $0.63 per share. RBC Capital downgraded Epizyme from Outperform to Sector Perform.
- Community Health Systems CYH slipped 11.4 percent to $4.82 following larger-than-expected Q3 loss.
- Symantec Corporation SYMC shares fell 11.3 percent to $28.53 after the company reported weak quarterly earnings and issued a lower guidance.
- FireEye Inc FEYE slipped 11.2 percent to $14.53. FireEye reported a narrower-than-expected loss for its third quarter, but issued a weak guidance for the current quarter.
- Tesla Inc TSLA shares slipped 6.2 percent to $301.34. Tesla reported a third-quarter loss of $2.92 per share. The electric carmaker delivered third-quarter sales of $2.98 billion, beating estimates by $680 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversBiotechnologyHealth CareMid-Day LosersMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in